Arabic Arabic English English French French German German
dark

Engitix Therapeutics appoints Dr Mike Burbridge as VP Oncology and Immuno-oncology

Engitix Ltd, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours and with two significant partnerships based on its pioneering proprietary human extracellular matrix drug discovery platform, announced that it has appointed Dr Mike Burbridge, as Vice President, Oncology & Immuno-oncology. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Expansions and Hirings Spark Surge of Growth in BioCapital Region

Next Post

Sherlock Biosciences’ CRISPR SARS-CoV-2 Test Selected as Finalist in “On the Rise” and Honorable Mention in “Health and Pandemic Response” Categories of Fast Company’s 2021 World Changing Ideas Awards

Related Posts
Total
0
Share